Can primaquine therapy for vivax malaria be improved?
The incidence and range of endemic malaria caused by Plasmodium vivax has expanded during the past 30 years. This parasite forms hypnozoites in the liver, creating a persistent reservoir of infection. Primaquine (PQ), introduced 50 years ago, is the only drug available to eliminate hypnozoites. Howe...
Κύριοι συγγραφείς: | Baird, J, Rieckmann, K |
---|---|
Μορφή: | Journal article |
Γλώσσα: | English |
Έκδοση: |
2003
|
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
Therapeutic principles of primaquine against relapse of Plasmodium vivax malaria
ανά: Baird, J
Έκδοση: (2018) -
Primaquine as anti-relapse therapy for Plasmodium vivax
ανά: Baird, J
Έκδοση: (1998) -
Primaquine therapy for malaria.
ανά: Baird, J, κ.ά.
Έκδοση: (2004) -
High-dose primaquine regimens against relapse of Plasmodium vivax malaria.
ανά: Krudsood, S, κ.ά.
Έκδοση: (2008) -
Treatment of primaquine-resistant Plasmodium vivax malaria.
ανά: Luzzi, G, κ.ά.
Έκδοση: (1992)